About this episode

The episode discusses late-breaking trials from ESCMID Global 2026 and their potential impact on medical practice.

The ESCMID Global Late Breakers series returns to Communicable ! Five CMI Communications editors – Marc Bonten, Josh Davis, Angela Huttner, Anne-Grete Märtson, and Erin McCreary – handpicked five late-breaking trials presented at ESCMID Global 2026 to summarise their findings and discuss whether the results will change their practice. This is part one of the two-part series. Trials presented are listed below and links to their respective sessions can be watched and rewatched on the ESCMID Global Virtual Platform. Links to corresponding publications, if available, and mentioned related articles are provided as well. The FAST trial ( Late-breaking research from JAMA ) Banerjee R, et al. Fast Antimicrobial Susceptibility Testing for Gram-Negative Bacteremia. The FAST Randomized Clinical Trial, doi: 10.1001/jama.2026.5487 Srinivasan A. A Multinational Trial of Rapid Antimicrobial Susceptibility Testing. Is FASTer Better?, doi: 10.1001/jama.2026.5504 The CEFMEC trial ( Poster session ) Hayakawa K, et al. Effectiveness of cefmetazole versus meropenem for invasive urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli , Antimicrob Agents Chemother…

People in this episode

Guests: Marc Bonten, Josh Davis, Angela Huttner, Anne-Grete Märtson, Erin McCreary

Topics covered

• clinical trials
• antimicrobial resistance
• infectious diseases
• medical research
• healthcare practices

Keywords

• ESCMID
• clinical trials
• FAST trial
• CEFME trial
• COBRA trial

Mentioned in this episode

Organizations: ESCMID

Books & works: FAST trial, CEFME trial, COBRA trial, JAMA, Antimicrob Agents Chemother

More episodes of Communicable

• Communicable E62: The 'prose' and cons of the POET trial – early oral antibiotic switch for endocarditis · September 6, 2026 · 52 min
• Communicable E61: We will make you love PK/PD, part 3 · August 23, 2026 · 53 min
• Communicable E60: Quarterly catch-up (August 2026 edition) · August 9, 2026 · 49 min
• Communicable E59: 'Ask me anything' – EUCAST and CLSI leadership explain · July 26, 2026 · 1h 9m
• Communicable E58: Reducing hospital-acquired pneumonia – the HAPPEN trial and how it happened · July 12, 2026 · 54 min
• Communicable E57: We will make you love PK/PD, part 2 · June 28, 2026 · 47 min

Explore listener stats, chart rankings, contacts and more on the Communicable podcast page.